No impact of first-line systemic therapy on quality of life of patients with metastatic breast cancer? Data from the MaLife-project.
Marschner, N., Tesch, H., Karcher, A., Ammon, A., Nusch, A., Boller, E., Spring, L., Jänicke, M., 2014.
Oncol Res Treat 37 (suppl 5)(V371), 111. doi:10.1159/000368945
